Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Research Services
Thoracic Oncology Group of is a Research Services brand in Sydney, NSW. A nonprofit, at thoraciconcology.org.au. It holds one address on record, all in Australia. It employs 10 people, on the record. It lists fundraising, education and networking among its specialties. One Australian registration (ABN) is a confirmed match. It is listed alongside ten similar brands, mostly in Research Services.
ABN47641984198
| THORACIC ONCOLOGY GROUP OF AUSTRALASIA LTD | ABN 47641984198 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Thoracic Oncology Group of Australasia (TOGA) is a charity and membership organisation of Australia and New Zealand-based multidisciplinary doctors, nurses, healthcare professionals, scientists, patients, supporters and caregivers who volunteer their time to design and conduct clinical research in thoracic cancers, including lung cancer and mesothelioma. TOGA clinical trials often utilise treatments not yet part of national healthcare reimbursement programs, expanding the affordable treatment options that can be offered throughout Australia and New Zealand and answering the questions that confront everyday treatment of thoracic cancers.
With a mission to prevent, treat and cure thoracic cancers through research, clinical trials, education and advocacy, TOGA exemplifies the successful integration between research, optimal healthcare and what matters to patients, through:
- collaborative critique of proposed clinical trial designs;
- education and advocacy for cutting-edge advances in thoracic cancer treatments;
- mentorship of clinicians who strive to improve outcomes for people with thoracic cancers through clinical research
Our charitable donations and fundraising programs support clinical trial activities which help to discover better ways to diagnose, treat and support people with lung cancer.
Our strategic plan for 2022-2025 is centred around building capacity, collaborations and a sustainable organisation to help realise our mission.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
One New South Wales entity on the ABR: THORACIC ONCOLOGY GROUP OF AUSTRALASIA LTD (ABN 47 641 984 198), high confidence.
10 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only. Primary: 6 Chifley Square, Level 1, Sydney, NSW 2000.
None linked to this brand.
Nine tags on the brand's own list, among them fundraising, education and networking.
13 profiles list Thoracic Oncology Group of Australasia as a peer. It lists ten peers of its own. Australia New Zealand Gynaecological Oncology Group (ANZGOG) and Melanoma and Skin Cancer Trials list it back.